Weinstock-Guttman B, Bermel R, Cutter G, Freedman MS, et al. Ocrelizumab treatment for relapsing-remitting multiple sclerosis after a suboptimal response to previous disease-modifying therapy: A nonrandomized controlled trial. Mult Scler 2021 Aug 12:13524585211035740. doi: 10.1177/13524585211035740.
PMID: 34382875